The value of cord serum interferon-gamma estimation in the prediction of first year allergies by El-Gamal, Yehia et al.
Egypt J Pediatr Allergy Immunol 2005; 3(1):10-18. 
10 
 
The value of cord serum interferon-gamma estimation in the prediction of 
first year allergies. 
 
INTRODUCTION 
Early abnormalities in immune development of 
allergic individuals may help defining disease 
pathogenesis and may direct future prevention 
strategies1. Atopy has been linked to skewing of 
immune responses away from a TH1 toward a TH2  
profile with subsequent imbalance between TH1 
cytokines such as interferon-γ (IFN-γ) and TH2 
cytokines such as IL-4, IL-5 and IL-132,3. 
The influence of IFN-γ on atopy and allergic 
inflammation seems to be pleiotropic. IFN-γ has got 
an inhibitory effect on mast cells and together with 
IL-12 it inhibits IL-5 production by T cells and 
activates TH1 responses
4,5. It may also inhibit IL-4 
and IL-13 induced IgE production6. On the other 
hand, IFN-γ has been found to maintain chronic 
allergic inflammation particularly in asthmatic 
airways7 and this may explain the elevated IFN-γ 
levels in chronic asthmatics in addition to the 
expected high level of TH2 cytokines
8,9. 
It was assumed that IFN-γ deficiency in newly 
born infants could be a risk factor for the 
development of atopic diseases and deficient 
production of this cytokine by cord blood 
mononuclear cells (CBMC) was demonstrated in 
infants with family history of atopy and those who 
developed allergic diseases during the first two 
years of life3,6,10. Nevertheless, Row and associates7 
identified elevated IFN-γ production by CD8+ T 
cells from cord blood samples and this was strongly 
associated with atopy development in high risk 
children at 2 years. It seems that the role of IFN-γ in 
progression from high risk status to active disease is 
less clear. 
The increasing prevalence of allergy has 
focused attention on primary prevention and the 
great need for early life prediction of allergy so that 
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“at-risk” children can be accurately defined and 
preventive measures promptly instituted11. Up till 
now, no test for allergy holds high predictivity and 
this was the stimulus for the study. It is aimed to 
evaluate the role of cord serum IFN-γ expression in 
the prediction of allergy within the first year of life 
and its possible relations to other relevant markers 
of allergic disease. The alterations in this cytokine 
may influence the future strategies for prevention 
and treatment in allergy-prone neonates. 
   
METHODS 
Study population: 
The study was conducted on 80 consecutive term 
deliveries that took place in the Maternity Hospital 
of Ain Shams University, Cairo. Preterm and post-
term deliveries were excluded to avoid interference 
Mothers: 
 The mothers were interrogated prior to labor for 
the duration of pregnancy, active or passive 
smoking, prenatal maternal illness and personal or 
family history of atopy. Atopic predisposition of the 
offspring or positive family history of atopy was 
defined as at least one parent, older sibling or 
second degree relative who has an atopic disease12. 
Neonates: 
The neonates were classified according to the 
family history of allergy (FHA) into two groups. 
The first group comprised 44 neonates (55%) with a 
negative FHA. These were 21 males and 23 females 
whose gestational ages ranged between 37 and 40 
weeks (mean 38.8 ± 1.2 weeks). Forty one neonates 
(93%) were born by normal vaginal delivery (NVD) 
and 3 (7%) were born by cesarean section (CS). 
Thirty six neonates (45%) with a positive FHA 
constituted the second group and they comprised 22 
males and 14 females. Their gestational ages ranged 
between 38 and 40 weeks (mean 38.0 ± 1.2 weeks). 
Thirty one babies (86%) were born by NVD and 
five (14%) were born by CS. 
The newly born babies underwent clinical 
evaluation at birth for the presence of congenital 
anomalies. Apgar scoring was estimated at 5 
minutes and scores ≥ 8 were considered normal 13.
Birth weight, crown heel length, and skull 
circumference measurements were recorded in 
relation to normal percentiles for gestational age14. 
The infants were followed up for a period of 1 year 
and the following was recorded: 
• Type of milk feeding whether breast, formula or 
mixed feeding. 
• Age of weaning in months. 
• Exposure to passive smoking. 
 
• Presence of symptoms and/or signs of atopic 
diseases such as: 
- Atopic eczema (atopic dermatitis). 
- Wheezing attacks relieved by β2-stimulants. 
- Urticaria and angioneurotic edema. 
- Allergic rhinitis, allergic conjunctivitis or both 
(allergic rhinoconjunctivitis). 
- Anaphylaxis. 
- Symptoms and signs suggestive of food allergy 
including gastrointestinal disorders. 
 
Study measurements: 
Umbilical cord whole blood samples (5 ml) were 
subjected to complete blood counting especially for 
eosinophils, basophils and platelets using coulter 
electronic automated system (Sysmex, K-model-
1000, Japan). Aliquots of serum were separated 
from another 5 ml sample by centrifugation at 1500 
rpm at room temperature. IFN-γ estimation in cord 
serum was performed by the ELISA technique 
(Boehringer Mannheim GmbH, Sandhofer Str. 116, 
D-68305 Mannheim). It is a photometric enzyme 
linked assay for the quantitative determination of 
human IFN-γ in streptavidin-coated microtiter 
plates. Serum total IgE was carried out by 
enzymatic immunoassay (Eurogenetics, Seppim, 
Zone industrielle, 61500 SEES, France). Serum 
total IgD was assayed by radio-immunodiffusion 
(BINDARID, The Binding Site LTD, Birmingham, 
B29 6AT, England). The method involves antigen 
diffusion radialy from a cylindrical well through an 
agarose gel containing an appropriate mono-
specific antibody. Antigen-antibody complexes then 
form a precipitin ring. A calibration curve was 
constructed by measuring the ring diameters 
produced by a number of samples of known 
concentration. The IgD concentration was 
determined by measuring the ring diameter and 
plotting it against the calibration curve. 
 
Statistical Analysis: 
Data were analyzed using a statistical Software 
package V.5 (StatSoft, Tulsa OK, USA). All 
numeric data were expressed as mean ± standard 
deviation (SD). Data were analyzed using the 
student “t” test to compare mean values. Non-
parametric variables were analyzed using the Man 
Whitney or Wilcoxon rank signed tests “z”. Pearson 
“r” correlation coefficient was used to determine 
the relationship between different numeric 
variables. Chi-square (χ2) test was used to compare 
the frequency of qualitative variables among the 
different groups. For all tests, a probability (p) of 
less than 0.05 was considered significant. 
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RESULTS 
Eighty babies were enrolled in this study and 
followed up for one year to look for symptoms and 
signs of allergic disorders. Their birth weight 
percentiles (mean 51.4 ± 25.5), crown heel length 
(mean 56.8 ± 22.5) and occipito-frontal skull 
circumference (mean 76.2 ± 18.9) percentile values 
ranged between the 10th and 95th for age. The Apgar 
scores at 5 minutes ranged from 7 up to 10 with a 
mean score of 8.7 ± 0.9. Seventy four mothers 
(92%) were healthy with no history of prenatal 
illness, while six (8%) had a positive history of 
prenatal maternal disease. Of these, two had 
gestational diabetes mellitus (DM), two had 
hypertension and two mothers gave a history of 
threatened abortion in the first trimester. 
Family history of allergy (FHA) was evident in 
36 infants (45%) while 44 infants (55%) did not 
have any history suggestive of atopy. Fifty three 
mothers were considered smokers by self-report, of 
whom two were active smokers and 51 were 
passive smokers. On the other hand, 27 mothers 
(34%) were not exposed to tobacco smoke by 
history. Follow up revealed that 36 infants (45%) 
were breast fed (BF), 33 (41%) were formula fed 
(AF) and 11 infants (14%) were both breast and 
formula fed in a mixed way (MF). The infants’ 
weaning age ranged from 2 to 6 months with a 
mean age of 3.4 ± 0.8 months. 
Cord serum immunoglobulin E (IgE) was 
below the detection limit in 69 neonates (86%) and 
was detectable in 11 (14%). In the latter group, the 
IgE levels ranged from 0.5 up to 15 IU/ml with a 
mean value of 7.6 ± 4 IU/ml. Cord serum 
interferon-gamma (IFN-γ) was undetectable in 64 
neonates (80%) while its level was measurable in 
16 neonates (20%). Their IFN-γ concentrations 
ranged from 1 up to 18 pg/ml with a mean value of 
9.27 ± 6.34 pg/ml and a median value of 10 pg/ml. 
The immunoglobulin D (IgD) in cord blood of the 
enrolled neonates was below the detection limit of 
the method employed. 
Follow up of the studied sample for one year 
revealed that 28 infants (35%) developed allergic 
disorders of whom 16 (57%) showed manifestations 
of atopic dermatitis, 8 developed recurrent 
wheezing attacks (28.6%), 3 had other forms of 
skin allergy including papular urticaria and/or hives 
and a single infant developed manifestations of 
allergic rhino-conjunctivitis. 
Of infants who developed allergic disorders, 19 
had a positive family history of atopy (68%). On 
the other hand, only 9 out of 28 infants (32%) with 
a negative family history of allergy developed a 
subsequent allergic disorder during the one year 
follow up period. Maternal allergy was associated 
with a higher frequency of allergy in the offspring; 
14 infants (74%) of the allergic group belonged to 
allergic mothers whether they had another allergic 
person in the family (in 4 infants) or not, while 5 
allergic infants (26%) had a history of allergy in the 
father ± another family member. 
The presence of a positive family history of 
atopy did not influence the cord serum IgE and 
IFN-γ levels or total leukocytic, eosinophil or 
platelet counts. However, the mean cord blood 
basophil count (CBBC) was higher in infants with a 
positive family history of allergy (mean 54.9 ± 
70.4/mm3) as compared to infants with no such 
history (mean 20.3 ± 45.1/mm3).  
Infants who did show frank allergic 
manifestations had significantly lower IFN-γ 
concentrations in their cord serum at birth as 
compared to infants who did not develop allergies 
by their first birthday (Fig. 1). Babies with 
measurable levels of IFN-γ in cord serum were 
comparable to the rest of the series in terms of cord
blood basophil and eosinophil counts. Although, the 
mean value of serum IgE seemed higher in infants 
with absent IFN-γ in cord blood samples, the 
difference did not reach statistical significance 
(Table 1). The cord serum IFN-γ concentrations 
correlated negatively with the total leucocytic, 
basophil and eosinophil (Fig. 2) counts. Moreover, 
a positive correlation could be elicited between the 
cord basophil and eosinophil counts of infants 
enrolled in the study (Fig. 3). 
Seven out of 11 infants (64%) with measurable 
IgE in their cord blood developed allergy 
subsequently. The IgE mean concentrations did not 
vary significantly between infants who developed 
allergies and those who did not but the number of 
neonates with measurable IgE in their cord sera was 
significantly higher among the allergic group. Also, 
both groups were comparable as far as their 
eosinophil and basophil counts were concerned 
(Table 2). 
Other parameters such as the gestational age, 
body weight, crown heel length, skull 
circumference at birth, Apgar score at 5 minutes 
and weaning age in months could not be 
significantly related to the subsequent development 
of allergy (Table 3). Also, the occurrence of allergic 
disorders during the first year was not influenced by 
the mode of delivery, prenatal maternal illness, 
congenital anomalies of babies, or history of 
maternal and/or paternal smoking in our series. 
Breast fed infants were comparable to those who 
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were formula fed or on mixed feeding as far as the 
subsequent development of allergy is concerned. 
However, the number of allergic infants on mixed 
feeding were significantly less than those on 
formula (Table 4). 
Infants who developed respiratory allergies 
such as  allergic rhinitis and bronchial asthma did 
not differ from those who had various dermal 
allergies such as atopic dermatitis, papular urticaria 
or hives in terms of basophil and eosinophil counts 
and cord serum IgE and IFN-γ expression. 
Gender did not influence any of the laboratory 
parameters of the enrolled neonates. Male and 
female babies were quite comparable in terms of 
hemoglobin concentration, TLC, CBBC, CBEC, 
platelet count, and cord serum IgE and IFN-γ at 
birth.
 















































z = 2.8 p<0.01 (significant) 
Figure 1. Variation of cord serum IFN-γ concentrations with the subsequent development of allergic disorders. 
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r = - 0.51 p<0.05 (significant) r = 0.6            p<0.001 (significant) 
Figure 2. Negative correlation between the 
eosinophil count and serum IFN-γ in cord blood. 
Figure 3. Positive correlation between the basophil 









Table 1. Relation of serum IFN-γ detectability to basophil and 
eosinophil counts and serum IgE levels in cord blood. 
Variable in 
cord blood 
IFN-γ absent IFN-γ detected Statistical 
analysis n Mean± SD n Mean± SD 
CBEC  
(/mm3) 
64 165.5±114.5 16 186.1±122.1 z = 0.62 
p = 0.54 
CBBC  
(/mm3) 
64 36±52.9 16 35.4±85 z = 1.0 
p = 0.32 
Serum IgE  
(IU/ml) 
8 7.9±3.5 2 3.8±4.6 z = 1.2 
p = 0.24 
CBBC: cord blood basophil count; CBEC: cord blood eosinophil count; IgE: immuno-





Table 2. Variation of cord blood basophil and eosinophil counts and cord 
serum IgE with the subsequent development of allergy. 
Variable in 
cord blood 
Non-allergic infants Infants with allergy Statistical 
analysis n Mean± SD n Mean± SD 
CBEC  
(/mm3) 
52 160.1±101.2 28 187.3±138.2 z = 0.56 
p = 0.57 
CBBC  
(/mm3) 
52 27.3±47.1 28 51.9±77.1 z = 1.27 
p = 0.21 
Serum IgE  
(IU/ml) 
4 7.3±2.1 6 7.0±4.9 z = 0.32 
p = 0.75 
CBBC: cord blood basophil count; CBEC: cord blood eosinophil count; IgE: immuno-





Table 3. Variation of some quantitative clinical variables 
with the subsequent development of allergy. 
Data 
Non-allergic infants 
(n = 52) 
Infants with allergy 
(n = 28) Statistical 
analysis 
Mean± SD Mean± SD 
Gestational age 
(weeks) 
38.9±0.8 38.7±1.1 t = 0.3 
p = 0.58 
Body weight 
(percentile) 
50±26.5 54.1±23.7 z = 0.7 
p = 0.48 
Crown-heel length 
(percentile) 
58.4±22.6 53.8±22.3 z = 0.89 
p = 0.37 
Skull circumference 
(percentile) 
74.7±19.7 78.9±17.2 z = 0.79 
p = 0.43 
Apgar score  
at 5 minutes 
8.5±0.9 8.6±0.8 z = 0.76 
p = 0.45 
Weaning age 
(months) 
3.5±0.8 3.4±0.7 t = 0.6 
p = 0.59 
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(n = 52) 
Infants with 
allergy 
(n = 28) 
Statistical 
analysis 
MOD CS 6 2 χ2 = 0.39 
p = 0.53 NVD 46 26 
Perinatal maternal disease Negative 49 25 χ2 = 0.64 
p = 0.42 Positive 3 3 
Congenital anomalies Negative 50 28 χ2 = 1.1 
p = 0.29 Positive 2 0 
Type of milk feeding 
FF 17 16 χ2 = 2.3 
p = 0.13 BF 25 11 
FF 17 16 χ2 = 5.4 
p = 0.02* MF 10 1 
BF 25 11 χ2 = 2.0 
p = 0.15 MF 10 1 
Maternal or paternal smoking Negative 16 11 χ2 = 0.6 
p = 0.44 Positive 36 17 
* Significant 
BF: breast fed; CS: Cesarean section; FF: formula fed; MF: mixed feeding; MOD: mode of delivery; NVD: normal vaginal delivery. 
 
DISCUSSION 
Twenty eight out of 80 neonates (35%) enrolled in 
this study developed allergic manifestations during 
the first year of life and this may reflect the rise in 
the prevalence of allergic symptoms in Egyptian 
infants. Of those who developed various allergies, 
19 (68%) had a positive family history of allergy 
(FHA). In other words, 19 (53%) out of 36 infants 
with a positive FHA showed symptoms and signs of 
allergy during the first year of life in comparison to 
9 (20%) out of 44 infants with a negative history. 
These findings, reinforce the concept that a positive 
FHA remains the dominant predictive factor for 
subsequent development of allergy sensitization and 
disease1,15. In a population based prospective study 
conducted on 1111 newborns who were followed 
up for 1 year, the family history of atopy was by far
the most sensitive factor in detecting infants at risk
of atopy and little was added by knowledge of cord 
blood IgE16. 
The most common allergic manifestation 
observed in our series was atopic dermatitis (57%) 
and this conforms with previous reports which also 
linked the development of atopic eczema to the 
positive parental or family history of atopy17. 
Maternal allergy conferred a higher allergy risk for
infants in our series suggesting that maternal factors 
can directly influence the immune development of 
the offspring. It is established that the induction of 
allergen specific T-cell memory is initiated in utero 
and it was previously reported that maternal history 
of allergy is inversely related to the perinantal IFN-
γ production capacity18. Prescott and associates19 
recently demonstrated that allergic disease at 6 
years of age was associated with significantly 
higher maternal responses to fetal alloantigens 
which suggests that events at the materno-fetal 
interface have an important influence on early 
immune development. The cytokine profiles of 
deciduas from allergic women were found different 
from those of deciduas from non-allergic women 
and this appeared to be related to cytokine 
production by cord blood mononuclear cells 
(CBMC) further enforcing the influence of maternal 
allergy on the fetal immune profile20. 
Among our series, infants who did show frank 
allergic manifestations during their first year of life 
had significantly lower IFN-γ concentrations in 
their cord serum at birth as compared to infants who
grew up without developing allergies (Fig. 1). This 
observation suggests a relation between cord serum 
IFN-γ expression and the subsequent development 
of allergic disorders. 
Liao and associates21 compared the difference 
in cytokine production by CBMC between 
newborns with high-risk for allergy [family allergy 
score (FAS) ≥ 3] and those with low risk [FAS = 0]. 
They found that increased production of IL-6 and 
decreased production of IFN-γ appeared to be the 
hallmark of newborns with high risk. Several 
investigators made the same conclusion from 
studies on cord or peripheral blood mononuclear 
cells3,6,22-24. The reduced cord blood secretion of 
IFN-γ and IL-10 were associated with subsequent 
sensitization to egg at 12 months in a follow up 
study6. The combination of food allergy and atopic 
dermatitis at 12 months in a high risk cohort was 
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the strongest risk factor for the development of 
asthma at 24 months of age25. 
An obstacle to the routine use of serum or 
plasma level of IFN-γ in research is the very low 
level of IFN-γ produced spontaneously by cord 
blood cells. Several investigators proved that 
CBMC, T cells and NK cells produce much lower 
levels of IFN-γ compared with adult mononuclear 
cells25,27. The low profile of IFN-γ in neonates was 
assumed to reflect the dominance of type 2 
immunity during the entire neonatal period whereas 
type 1 immunity dominates during childhood 
leading to a lower plasma IFN-γ concentration in 
neonates from non-atopic parents than in healthy 
children28. 
The predictive value of neonatal IFN-γ for 
allergy was questioned in some studies. Although 
infants at genetic risk (family history) of allergy 
definitely had weaker IFN-γ responses in one study, 
those who developed allergic disease at 6 years of 
age had almost comparable neonatal responses (p = 
0.05) compared to those with no symptoms1. The 
same conclusion was made by Rowe and 
coworkers7 who identified, by logistic regression 
analysis, that although high genetic risk is 
associated with attenuated neonatal IFN-γ 
responses, its production by CD8+ T cells may 
synergize with TH2 cytokines in driving atopy 
development in children with high risk. This may 
explain the reported elevation in IL-4, IL-5 and 
IFN-γ production by sputum CD4+ and CD8+ cells 
in adult asthmatics29. 
The cord serum IFN-γ predictivity in our series 
seemed higher than that of IgE and no significant 
correlation could link both of them. Cord serum IgE 
was detectable in 7 (25%) out of the 28 neonates 
who developed subsequent allergies while it was 
detectable in 4 neonates (8%) out of 52 who did not 
show allergic manifestations. IgE does not cross the 
placenta, but fetuses are capable of synthesizing it. 
The human fetus has B cells that are primed to 
undergo IgE class switching from the earliest stages 
of ontogeny and can produce endogenous IgE by 20 
weeks’ gestation. However, IgE producing cells 
were found rare until 9 months after birth. This may 
explain the low detectability of IgE in cord blood at 
birth30. 
Cord blood IgE was claimed to be a significant 
predictor for urticaria due to food allergy at 12 
months but not for other allergic disorders31, and 
that the positive correlation between cord blood IgE 
expression and serum total IgE levels in the first 2 
years of life31 is of lower significance during 
childhood16. However, there seems to be a general 
agreement that a high neonatal IgE concentration is 
connected with later allergic disease but still with a 
low positive predictive value33. 
The cord blood eosinophil count correlated 
negatively with the cord serum IFN-γ in our series 
meaning that the lower the IFN-γ was the higher got 
the eosinophil count in cord blood (Fig. 2). This 
may be due to lack of the inhibitory effects of IFN-γ 
on IL-5, the major cytokine in eosinophil 
differentiation, proliferation, and survival. IFN-γ 
producing CD4+ T cells were reported to be 
inversely correlated with peripheral blood 
eosinophils and had a significant correlation with 
airway hyperresponsivieness in atopic and non 
atopic asthmatic children2. Again, the cord blood 
basophils were inversely related to the cord serum 
IFN-γ in our series probably reflecting the influence 
of IFN-γ on TH2 cytokines which may enhance 
basophil differentiation and release. A positive 
correlation was found to link the eosinophil and 
basophil counts in the cord blood samples (Fig. 3) 
reflecting the common developmental lineage of 
both cells and the hemopoietic influence of IL-5 on 
their proliferation34. 
The total serum IgD was reported to be elevated 
in atopic than non-atopic subjects35,36. We therefore 
sought to investigate its expression in cord serum as 
well as any possible predictive value. IgD levels in 
our series were below the detection limit of the 
method employed (5mg/L). Haraldsson and 
colleagues37 noted that there was no IgD in cord 
serum. They detected very low levels of IgD in 
older infants and young children that gradually 
increased until the age of 10 then decreased with 
age. It was stated that few nanograms of IgD are 
actually present in cord serum and are thus not 
easily detectable38 and that serum IgD is positively 
correlated to age throughout childhood. 
The mode of delivery in our series did not 
influence the cord serum IFN-γ results or the 
subsequent development of allergy. Brown and 
coworkers40 demonstrated a higher level of IFN-γ 
and IL-12 production from stimulated CBMC of 
vaginally delivered infants as compared to infants 
born by unlabored cesarean section. The fact that 
we measured spontaneously produced free serum 
IFN-γ rather than its production from CBMC may 
count for the difference. In the current study, 
measuring IFN-γ in the cord serum was more 
simple and less tedious than tracing its release from
CBMC but it was obviously less expressed. 
When we compared the allergic to non-allergic 
infants in terms of all variables studied (Tables 1-
4), the only significant difference observed was the 
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higher frequency of first year allergy among 
formula fed infants in comparison to those on 
mixed feeding (Table 4). This might imply some 
protective effect for breast feeding although infants 
on pure breast feeding did not show lower affection 
rates in our series. The findings are indeed limited 
by the sample size and the short duration of follow 
up. 
In conclusion, cord serum IFN-γ at birth was 
found significantly low in infants who subsequently 
developed skin and/or respiratory allergies during 
the first year of life. Cord serum IFN-γ detectability 
at birth seemed higher than that of total IgE. Family 
history of atopy is still the most important predictor 
of allergy and can determine neonates at high risk.
Indeed, combining more than one factor would 
improve the predictability such as the presence of a 
positive family history with the reduced IFN-γ 
and/or elevated IgE in cord serum. Wider scale 
studies are needed to be able to accurately define 
the predictive value of each marker in terms of 
sensitivity, specificity and overall performance. 
Experimental trials on the effect of recombinant 
IFN-γ or IFN-γ inducing cytokines (IL-12, IL-15 
and IL-18) on the expression of allergic 
manifestations could be worthwhile. 
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